ZFP14 Regulates Cancer Cell Growth and Migration by Modulating p53 Protein Stability as Part of the MDM2 E3 Ubiquitin Ligase Complex

por Mohibi, Shakur, Chen, Xinbin, Zhang, Jin
Publicado 2022

Mouse models of estrogen receptor-positive breast cancer

por Mohibi, Shakur, Mirza, Sameer, Band, Hamid, Band, Vimla
Publicado 2011

Epidermal Growth Factor Receptor activation promotes ADA3 acetylation through the AKT-p300 pathway

por Srivastava, Shashank, Mohibi, Shakur, Mirza, Sameer, Band, Hamid, Band, Vimla
Publicado 2017

Ferredoxin reductase and p53 are necessary for lipid homeostasis and tumor suppression through the ABCA1–SREBP pathway

por Zhang, Yanhong, Mohibi, Shakur, Vasilatis, Demitria M., Chen, Mingyi, Zhang, Jin, Chen, Xinbin
Publicado 2022

p73α1, an Isoform of the p73 Tumor Suppressor, Modulates Lipid Metabolism and Cancer Cell Growth via Stearoyl-CoA Desaturase-1

por Rabow, Zachary, Laubach, Kyra, Kong, Xiangmudong, Shen, Tong, Mohibi, Shakur, Zhang, Jin, Fiehn, Oliver, Chen, Xinbin
Publicado 2022

ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC

por Griffin, Nicolas I., Sharma, Gayatri, Zhao, Xiangshan, Mirza, Sameer, Srivastava, Shashank, Dave, Bhavana J., Aleskandarany, Mohammed, Rakha, Emad, Mohibi, Shakur, Band, Hamid, Band, Vimla
Publicado 2016

Alteration/deficiency in activation-3 (Ada3) plays a critical role in maintaining genomic stability

por Mirza, Sameer, Katafiasz, Bryan J., Kumar, Rakesh, Wang, Jun, Mohibi, Shakur, Jain, Smrati, Gurumurthy, Channabasavaiah Basavaraju, Pandita, Tej K., Dave, Bhavana J., Band, Hamid, Band, Vimla
Publicado 2012

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients

por Mirza, Sameer, Rakha, Emad A., Alshareeda, Alaa, Mohibi, Shakur, Zhao, Xiangshan, Katafiasz, Bryan J., Wang, Jun, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Ellis, Ian O., Green, Andrew R., Band, Hamid, Band, Vimla
Publicado 2013

Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients

por Zhao, Xiangshan, Mirza, Sameer, Alshareeda, Alaa, Zhang, Ying, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Kim, Jun Hyun, Mohibi, Shakur, Goswami, Monica, Lele, Subodh M., West, William, Qiu, Fang, Ellis, Ian O., Rakha, Emad A., Green, Andrew R., Band, Hamid, Band, Vimla
Publicado 2012